Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetic Testing | 11 | 2021 | 1095 | 1.390 |
Why?
|
| Education, Medical, Undergraduate | 2 | 2021 | 159 | 0.930 |
Why?
|
| Genetic Counseling | 3 | 2018 | 246 | 0.680 |
Why?
|
| Financing, Personal | 1 | 2020 | 10 | 0.660 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2018 | 52 | 0.560 |
Why?
|
| Ambulatory Care Facilities | 1 | 2020 | 241 | 0.560 |
Why?
|
| Autism Spectrum Disorder | 5 | 2021 | 430 | 0.520 |
Why?
|
| Parents | 5 | 2020 | 1076 | 0.520 |
Why?
|
| Students, Medical | 1 | 2021 | 362 | 0.520 |
Why?
|
| Schools, Medical | 2 | 2021 | 122 | 0.500 |
Why?
|
| Genomics | 6 | 2021 | 1645 | 0.500 |
Why?
|
| Health Knowledge, Attitudes, Practice | 6 | 2020 | 897 | 0.500 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 482 | 0.450 |
Why?
|
| Quality Improvement | 1 | 2018 | 695 | 0.380 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2013 | 82 | 0.370 |
Why?
|
| Genes, Retinoblastoma | 1 | 2011 | 21 | 0.370 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2012 | 92 | 0.360 |
Why?
|
| Retinoblastoma Protein | 1 | 2011 | 84 | 0.360 |
Why?
|
| Genetics | 1 | 2011 | 24 | 0.360 |
Why?
|
| Health Services Needs and Demand | 1 | 2012 | 174 | 0.350 |
Why?
|
| Muscle Weakness | 1 | 2012 | 93 | 0.350 |
Why?
|
| Muscular Atrophy | 1 | 2012 | 90 | 0.350 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2012 | 112 | 0.340 |
Why?
|
| Camurati-Engelmann Syndrome | 1 | 2010 | 2 | 0.340 |
Why?
|
| Retinoblastoma | 1 | 2011 | 113 | 0.330 |
Why?
|
| Cataract | 1 | 2012 | 169 | 0.330 |
Why?
|
| Retinal Neoplasms | 1 | 2011 | 102 | 0.330 |
Why?
|
| Ovary | 2 | 2016 | 372 | 0.330 |
Why?
|
| Bone Diseases, Developmental | 1 | 2010 | 60 | 0.330 |
Why?
|
| Health Educators | 2 | 2020 | 7 | 0.310 |
Why?
|
| Hypopigmentation | 1 | 2009 | 11 | 0.310 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2009 | 47 | 0.310 |
Why?
|
| Puberty, Precocious | 1 | 2009 | 29 | 0.300 |
Why?
|
| Developmental Disabilities | 3 | 2019 | 748 | 0.300 |
Why?
|
| Ectodermal Dysplasia | 2 | 2024 | 46 | 0.300 |
Why?
|
| Community Health Workers | 2 | 2020 | 77 | 0.290 |
Why?
|
| Aneuploidy | 1 | 2009 | 144 | 0.290 |
Why?
|
| Mosaicism | 1 | 2009 | 250 | 0.270 |
Why?
|
| Craniosynostoses | 2 | 2024 | 134 | 0.260 |
Why?
|
| Mutation | 6 | 2024 | 6255 | 0.250 |
Why?
|
| Heterozygote | 2 | 2024 | 718 | 0.210 |
Why?
|
| Curriculum | 3 | 2021 | 762 | 0.210 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2016 | 3357 | 0.200 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2024 | 156 | 0.190 |
Why?
|
| Humans | 26 | 2024 | 132327 | 0.180 |
Why?
|
| Surveys and Questionnaires | 5 | 2020 | 3975 | 0.180 |
Why?
|
| Proteins | 2 | 2019 | 1066 | 0.170 |
Why?
|
| Needs Assessment | 2 | 2019 | 179 | 0.170 |
Why?
|
| DNA Mutational Analysis | 2 | 2012 | 826 | 0.160 |
Why?
|
| Dynamins | 1 | 2019 | 45 | 0.150 |
Why?
|
| Office Visits | 1 | 2018 | 78 | 0.140 |
Why?
|
| Child | 11 | 2024 | 25791 | 0.140 |
Why?
|
| Patient Education as Topic | 1 | 2020 | 460 | 0.130 |
Why?
|
| Health Education | 1 | 2019 | 232 | 0.130 |
Why?
|
| Female | 17 | 2024 | 70818 | 0.130 |
Why?
|
| Education | 1 | 2018 | 111 | 0.130 |
Why?
|
| Adult | 11 | 2020 | 31602 | 0.130 |
Why?
|
| Sexual Development | 1 | 2016 | 24 | 0.130 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2016 | 36 | 0.130 |
Why?
|
| Brain Diseases | 1 | 2019 | 307 | 0.120 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2016 | 45 | 0.120 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 481 | 0.110 |
Why?
|
| Craniofacial Abnormalities | 2 | 2019 | 254 | 0.110 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2019 | 551 | 0.110 |
Why?
|
| Seizures | 1 | 2019 | 895 | 0.110 |
Why?
|
| Child, Preschool | 7 | 2024 | 14843 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 1140 | 0.100 |
Why?
|
| Qualitative Research | 2 | 2016 | 660 | 0.100 |
Why?
|
| DNA Polymerase gamma | 1 | 2012 | 20 | 0.090 |
Why?
|
| Glutarates | 1 | 2012 | 37 | 0.090 |
Why?
|
| Ovarian Diseases | 1 | 2012 | 27 | 0.090 |
Why?
|
| Neoplasms | 2 | 2020 | 2947 | 0.090 |
Why?
|
| Eye Enucleation | 1 | 2011 | 45 | 0.090 |
Why?
|
| Mental Disorders | 1 | 2019 | 891 | 0.090 |
Why?
|
| Male | 13 | 2024 | 65037 | 0.090 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2015 | 461 | 0.090 |
Why?
|
| DNA, Neoplasm | 1 | 2011 | 296 | 0.080 |
Why?
|
| Genetics, Medical | 1 | 2011 | 122 | 0.080 |
Why?
|
| Risk Management | 1 | 2011 | 68 | 0.080 |
Why?
|
| Age of Onset | 1 | 2012 | 625 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 947 | 0.080 |
Why?
|
| Osteochondrodysplasias | 1 | 2010 | 68 | 0.080 |
Why?
|
| Syndrome | 2 | 2011 | 1171 | 0.080 |
Why?
|
| Texas | 4 | 2020 | 3628 | 0.080 |
Why?
|
| Phenotype | 2 | 2024 | 4545 | 0.070 |
Why?
|
| Genome, Human | 1 | 2015 | 1330 | 0.070 |
Why?
|
| Referral and Consultation | 1 | 2012 | 569 | 0.070 |
Why?
|
| Chromosome Aberrations | 1 | 2011 | 591 | 0.070 |
Why?
|
| Models, Molecular | 1 | 2012 | 1118 | 0.070 |
Why?
|
| Rare Diseases | 1 | 2010 | 208 | 0.070 |
Why?
|
| Radiography | 1 | 2010 | 818 | 0.070 |
Why?
|
| Retrospective Studies | 2 | 2020 | 17352 | 0.070 |
Why?
|
| DNA Repair | 1 | 2011 | 569 | 0.070 |
Why?
|
| Physicians | 2 | 2011 | 634 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 2067 | 0.070 |
Why?
|
| Mutation, Missense | 3 | 2019 | 936 | 0.070 |
Why?
|
| Patient Care Team | 1 | 2011 | 569 | 0.070 |
Why?
|
| Infant | 4 | 2024 | 13184 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 2011 | 464 | 0.060 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2024 | 51 | 0.050 |
Why?
|
| Limb Deformities, Congenital | 1 | 2024 | 112 | 0.050 |
Why?
|
| Young Adult | 2 | 2019 | 9936 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 5403 | 0.040 |
Why?
|
| Pedigree | 2 | 2016 | 1725 | 0.040 |
Why?
|
| Medical History Taking | 1 | 2020 | 114 | 0.040 |
Why?
|
| Self Efficacy | 1 | 2020 | 209 | 0.040 |
Why?
|
| Perception | 1 | 2021 | 237 | 0.040 |
Why?
|
| Awareness | 1 | 2019 | 80 | 0.040 |
Why?
|
| Exome | 2 | 2015 | 1086 | 0.040 |
Why?
|
| Peroxisomes | 1 | 2019 | 42 | 0.040 |
Why?
|
| Muscles | 1 | 2019 | 251 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2011 | 8563 | 0.040 |
Why?
|
| Decision Making | 2 | 2016 | 693 | 0.040 |
Why?
|
| GTP Phosphohydrolases | 1 | 2019 | 156 | 0.040 |
Why?
|
| Language Development Disorders | 1 | 2019 | 179 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 2686 | 0.040 |
Why?
|
| Base Sequence | 2 | 2012 | 2990 | 0.030 |
Why?
|
| Neuroglia | 1 | 2019 | 213 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 901 | 0.030 |
Why?
|
| Psychometrics | 1 | 2021 | 693 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2019 | 507 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2019 | 412 | 0.030 |
Why?
|
| Sex Determination Processes | 1 | 2016 | 11 | 0.030 |
Why?
|
| Karyotype | 1 | 2016 | 31 | 0.030 |
Why?
|
| Androgen-Insensitivity Syndrome | 1 | 2016 | 26 | 0.030 |
Why?
|
| Gonads | 1 | 2016 | 34 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1452 | 0.030 |
Why?
|
| Autistic Disorder | 1 | 2019 | 387 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2015 | 67 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2016 | 362 | 0.030 |
Why?
|
| Alleles | 1 | 2019 | 1682 | 0.030 |
Why?
|
| Testis | 1 | 2016 | 424 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 3019 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 2019 | 830 | 0.030 |
Why?
|
| Mitochondria | 1 | 2019 | 754 | 0.030 |
Why?
|
| United States | 2 | 2019 | 11617 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2019 | 757 | 0.030 |
Why?
|
| Intellectual Disability | 1 | 2019 | 1094 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2019 | 1597 | 0.020 |
Why?
|
| Epilepsy | 1 | 2019 | 892 | 0.020 |
Why?
|
| Siblings | 1 | 2012 | 202 | 0.020 |
Why?
|
| Chromosome Breakage | 1 | 2011 | 158 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2012 | 268 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2012 | 281 | 0.020 |
Why?
|
| Genes, BRCA2 | 1 | 2011 | 49 | 0.020 |
Why?
|
| Genes, BRCA1 | 1 | 2011 | 61 | 0.020 |
Why?
|
| Homozygote | 1 | 2012 | 548 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2011 | 165 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2012 | 301 | 0.020 |
Why?
|
| Middle Aged | 2 | 2020 | 28870 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2011 | 292 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2011 | 775 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 578 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2011 | 578 | 0.020 |
Why?
|
| DNA Replication | 1 | 2011 | 353 | 0.020 |
Why?
|
| Neurons | 1 | 2019 | 2021 | 0.020 |
Why?
|
| Risk | 1 | 2011 | 763 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2019 | 6539 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 2696 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 3193 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 3838 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 20522 | 0.010 |
Why?
|
| Animals | 1 | 2019 | 35138 | 0.010 |
Why?
|